Fresenius Medical Care Corporation (NYSE:FMS) – Equities research analysts at SunTrust Banks reduced their FY2017 earnings per share (EPS) estimates for shares of Fresenius Medical Care Corporation in a report issued on Thursday. SunTrust Banks analyst D. Macdonald now forecasts that the company will earn $2.30 per share for the year, down from their prior forecast of $2.35. SunTrust Banks also issued estimates for Fresenius Medical Care Corporation’s Q4 2017 earnings at $0.61 EPS, Q3 2018 earnings at $0.65 EPS, Q4 2018 earnings at $0.65 EPS, FY2018 earnings at $2.55 EPS, Q1 2019 earnings at $0.66 EPS, Q2 2019 earnings at $0.69 EPS, Q3 2019 earnings at $0.70 EPS and FY2019 earnings at $2.76 EPS.

WARNING: This story was published by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/11/06/fresenius-medical-care-corporation-to-post-fy2017-earnings-of-2-30-per-share-suntrust-banks-forecasts-fms.html.

A number of other analysts also recently issued reports on the stock. Zacks Investment Research raised shares of Fresenius Medical Care Corporation from a “sell” rating to a “hold” rating and set a $53.00 price target on the stock in a report on Monday, October 9th. BidaskClub downgraded shares of Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Royal Bank Of Canada reissued a “hold” rating and set a $44.00 price target on shares of Fresenius Medical Care Corporation in a report on Wednesday, September 13th. Finally, DZ Bank AG reissued a “buy” rating on shares of Fresenius Medical Care Corporation in a report on Monday, August 7th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. Fresenius Medical Care Corporation presently has an average rating of “Hold” and a consensus target price of $48.50.

Shares of Fresenius Medical Care Corporation (FMS) opened at $48.32 on Monday. Fresenius Medical Care Corporation has a twelve month low of $38.05 and a twelve month high of $50.22. The stock has a market cap of $29,751.69, a price-to-earnings ratio of 21.67, a P/E/G ratio of 2.13 and a beta of 0.45. The company has a current ratio of 1.22, a quick ratio of 0.98 and a debt-to-equity ratio of 0.55.

A number of institutional investors and hedge funds have recently bought and sold shares of FMS. UBS Asset Management Americas Inc. lifted its holdings in Fresenius Medical Care Corporation by 3.6% during the second quarter. UBS Asset Management Americas Inc. now owns 2,357 shares of the company’s stock valued at $114,000 after purchasing an additional 81 shares in the last quarter. Pacer Advisors Inc. purchased a new position in Fresenius Medical Care Corporation during the second quarter valued at $179,000. FFT Wealth Management LLC purchased a new position in Fresenius Medical Care Corporation during the second quarter valued at $201,000. HPM Partners LLC purchased a new position in Fresenius Medical Care Corporation during the second quarter valued at $221,000. Finally, YorkBridge Wealth Partners LLC lifted its holdings in Fresenius Medical Care Corporation by 19.4% during the second quarter. YorkBridge Wealth Partners LLC now owns 4,613 shares of the company’s stock valued at $222,000 after purchasing an additional 749 shares in the last quarter. 2.62% of the stock is currently owned by institutional investors and hedge funds.

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Earnings History and Estimates for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.